DEPARTMENT: Office of the County Manager
FILE TYPE: Regular Action
TITLE
title
Authorization Of County Staff To Execute All Necessary Documents To Ensure County Participation In Multistate Settlements Relating To Opioid Manufactures And Pharmacies, And Amendment Of Minnesota Opioids State-Subdivision Memorandum Of Agreement
end
PURPOSE/ACTION REQUESTED
Hold a closed executive session.
SUMMARY
The Dakota County Attorney has advised that prior to closing a County Board meeting, pursuant to the Open Meeting Law, Minn. Stat. Ch. 13D, the County Board must resolve by majority vote to close the meeting.
RECOMMENDATION
recommendation
The County Manager has recommended that a closed executive session be held pursuant to attorney-client privilege during the Dakota County Board meeting of February 7, 2023, to discuss the following:
* the legal strategy for participating in the settlements with Teva Pharmaceutical Industries Ltd, Allergan Finance, LLC and Allergan Limited, CVS Health Corporation and CVS Pharmacy, Inc., Walgreen Co., and Walmart Inc.
end
EXPLANATION OF FISCAL/FTE IMPACTS
Fiscal impact will be discussed in closed session.
? None ? Current budget ? Other
? Amendment Requested ? New FTE(s) requested
RESOLUTION
body
WHEREAS, the State of Minnesota and numerous Minnesota cities and counties, including Dakota County, are engaged in nationwide civil litigation against manufacturers and distributors of prescription opioids related to the opioid crisis; and
WHEREAS, the Minnesota Attorney General has signed on to multistate settlement agreements with opioid manufacturers Teva Pharmaceutical Industries Ltd, Allergan Finance, LLC and Allergan Limited and several pharmacies, CVS Health Corporation and CVS Pharmacy, Inc., Walgreen Co., and Walmart Inc. ("Settling Defendants"), but those settlement agreements are still subject to sign-on by local governments and final agreement by the compan...
Click here for full text